M Löbig
About
In The Last Decade
M Löbig
17 papers receiving 357 citations
Peers
Comparison fields: 5 of 63
- Epidemiology 137
- Endocrinology, Diabetes and Metabolism 137
- Physiology 103
- Molecular Biology 86
- Endocrine and Autonomic Systems 77
Countries citing papers authored by M Löbig
This map shows the geographic impact of M Löbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Löbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Löbig more than expected).
Fields of papers citing papers by M Löbig
This network shows the impact of papers produced by M Löbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Löbig. The network helps show where M Löbig may publish in the future.
Co-authorship network of co-authors of M Löbig
This figure shows the co-authorship network connecting the top 25 collaborators of M Löbig. A scholar is included among the top collaborators of M Löbig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Löbig. M Löbig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 10 | |
| 3 | 16 | |
| 4 | 13 | |
| 5 | Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study. | 5 |
| 6 | Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease. | 10 |
| 7 | 10 | |
| 8 | 6 | |
| 9 | 12 | |
| 10 | Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus. | 1 |
| 11 | 38 | |
| 12 | Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin. | 9 |
| 13 | 21 | |
| 14 | Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. | 144 |
| 15 | Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid). | 8 |
| 16 | 34 | |
| 17 | Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.